Stock 2E40 PHAXIAM THERAPEUTICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart PHAXIAM Therapeutics S.A. Deutsche Boerse AG

Equities

2E40

FR001400K4B1

Delayed Deutsche Boerse AG
Other stock markets
 08:15:12 01/07/2024 BST 		5-day change 1st Jan Change
1.95 EUR +3.17% Intraday chart for PHAXIAM Therapeutics S.A. -1.02% -56.18%
06-28 Would you like some more inflation? Our Logo
06-28 Phaxiam: fewer funds raised than expected CF
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 113B
ARGENX SE Stock argenx SE
 26.02B -
BIONTECH SE Stock BioNTech SE
 19.39B -
GENMAB A/S Stock Genmab A/S
 15.91B
  1. Stock Market
  2. Equities
  3. PHXM Stock
  4. 2E40 Stock
  5. Charts PHAXIAM Therapeutics S.A.
  6. Sector Chart